Treatment of Alzheimer's disease: current status and new perspectives.
about
NMDA Receptor Function During Senescence: Implication on Cognitive PerformanceReelin and Neuropsychiatric Disorders.The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseaseInhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by CitrateRAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.Challenges associated with metal chelation therapy in Alzheimer's diseaseAcupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats.NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex.Multidisciplinary team meetings (MDTM) in detection of Alzheimer's disease: data from the IDEM study.A brief overview of amyloids and Alzheimer's disease.In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.Neurogenesis and Alzheimer's disease.New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production.Linarin Inhibits the Acetylcholinesterase Activity In-vitro and Ex-vivoWhy do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironmentConcepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.Antiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization.Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer's Rodent Models.Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Clinical aspects of inflammation in Alzheimer's disease.Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Emerging therapeutics for Alzheimer's disease.An update on pharmacological approaches to neurodegenerative diseases.Lithium: a novel treatment for Alzheimer's disease?Construction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR AssayEfficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil.On the hypes and falls in neuroprotection: targeting the NMDA receptor.Donepezil for Alzheimer's disease.Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.Oxidative stress and transcriptional regulation in Alzheimer diseaseIdentification of 4-aminoquinoline core for the design of new cholinesterase inhibitors
P2860
Q26770902-E0E0A742-6961-4F72-98AC-951716412377Q28072540-D28E9A4D-3247-4E12-83D8-8AADFE155079Q28251394-B95A4B21-DA4B-443E-92E4-95A872415F38Q33514614-FF9A94A3-A8BB-4576-A662-14641F76617CQ33607305-18CAE3CD-1C27-4440-BF9E-647FC6949B0DQ33792474-2572A481-0525-4754-9390-3C4F1A63A2C2Q34084791-8884B482-A13D-4F92-911B-371643DF2644Q34099450-9F9B6C09-B8FC-4288-B0FC-A3E029D08EF7Q34268232-F9EE7D32-4179-4DEF-903E-7A2FF0247CE1Q34376159-AA669BC1-C4B3-4D85-92FE-91DAB645507FQ34567875-8C42305E-FFD9-4B95-B9BF-F660F20AD14BQ34868191-A9F291D2-22AA-4868-917E-D0FDF2AA0FCCQ35103820-474C81FF-E1F3-42D9-BAD3-1BCCA6DD28CBQ35161731-A79496A8-960B-44DC-8A6B-91E59FF30425Q35199867-8F12B577-56B5-4E66-8506-B4E489FCABBDQ35538511-1B708ABF-0F1D-42CE-AE1D-253D83FF0ABBQ35598799-F31598FE-CD3E-4A73-992E-A6D032ADDC6CQ35822309-CB5BDD8D-1CF7-4B3A-849E-963C2C00E8A7Q35897922-4833F160-57B7-46DD-BE45-28D4972055A0Q35956065-6EDDD5A0-C4A1-4BF2-A1C8-58879CD459CFQ36099316-8D085D47-9A2F-448C-9930-C117D7392AE3Q36135529-C9817280-3E8B-414A-8655-8D62A9016648Q36143785-B9CC75F8-5488-4BA1-8AF4-3046385C29CCQ36156212-DD7DAF15-DCBB-4725-8CB7-436974B835B6Q36158803-FED3596F-1149-47F8-A28E-FB793110F54BQ36174613-AE1B67BB-303E-4D49-A487-0662EA3E1E98Q36310524-72AC81E2-5DB0-4C6F-BECB-5BAC48414CD1Q36364213-F5961783-7521-492E-BD7A-7F938CD58DE9Q36378028-DA02DF7E-4345-40AD-84C4-6B7920EA0F64Q36475090-F335634B-290B-43FC-86EC-81DDAF107A2BQ36492347-65AC90B9-2999-44C6-9662-97B22B47284EQ36677402-47B59105-70C5-4C15-A4E8-88229BB447C5Q36905840-F6916DF9-2394-4617-8F8B-0F2B7732190CQ36910522-6713D7EF-7539-4F82-B77B-950418007172Q36932284-29B024CC-C6BD-47AC-B281-CB309BF782D2Q36958209-E31DD157-F956-42C9-9EAA-5411B86A42B7Q36972671-B17D614E-538D-4DF9-9C0D-7830A4A1A820Q37030598-8AE76622-6E36-4679-955C-F805427B4435Q37036247-0C9728F7-437E-4C11-91B0-38B97F79F606Q37087345-00BAB17C-EC59-4200-95B9-4CD0CF392800
P2860
Treatment of Alzheimer's disease: current status and new perspectives.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of Alzheimer's disease: current status and new perspectives.
@ast
Treatment of Alzheimer's disease: current status and new perspectives.
@en
type
label
Treatment of Alzheimer's disease: current status and new perspectives.
@ast
Treatment of Alzheimer's disease: current status and new perspectives.
@en
prefLabel
Treatment of Alzheimer's disease: current status and new perspectives.
@ast
Treatment of Alzheimer's disease: current status and new perspectives.
@en
P1433
P1476
Treatment of Alzheimer's disease: current status and new perspectives
@en
P2093
Philip Scheltens
P304
P356
10.1016/S1474-4422(03)00502-7
P577
2003-09-01T00:00:00Z